Product development

SALMOSS HAPS-COL

Our second-generation biomaterial, Salmoss HAPS-COL, builds on the osteoconductive properties of our original HAPS product by incorporating Type I collagen to the salmon-derived hydroxyapatite.

This innovative composite mirrors the natural composition of human bone (70% hydroxyapatite, 30% collagen), offering enhanced handling and adaptability during clinical procedures. Its ideal consistency can be easily achieved with saline solution—no need for blood centrifugation or IV interventions—making it a ready-to-use, patient-friendly solution for bone regeneration.

Properties

Explore the breakthrough properties of SALMOSS HAPS COL a non-mammal derived xenograft that surpasses current alternatives, delivering exceptional osteoconductive and osteogenic results in diverse clinical scenarios for dentistry and medicine.

Benefits

SALMOSS BIOTECH revolutionizes bone grafting, catering to kosher and halal communities without cultural or religious constraints. It mitigates prion bovine risks and eliminates human organ donation concerns. Our efficient production adheres to ESG standards, promoting a circular economy, community empowerment, and environmental protection.

Fields of Application

SALMOSS HAPS COL, a top-tier osteoconductive and osteogenic material, is ideal for various bone reconstruction procedures, from life-saving surgeries to routine dental interventions. Its applications span dentoalveolar reconstruction, trauma-induced bone formation, and bony tissue recovery in Oncology, offering versatility across medical disciplines.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

SALMOSS Biotech

We harness the power of science to transform ideas into solutions, creating a positive impact on global health and contributing to a sustainable future.

Quick Links

About Us

Product Development

Foundation